


Vaccentis
Biotechnology Research • Stadtkreis 1 Altstadt, Zurich, Switzerland • 1-10 Employees
Company overview
| Headquarters | Gerechtigkeitsgasse, 25, Zürich , Switzerland 8001, CH |
| Website | |
| NAICS | 541714 |
| SIC | 384 |
| Keywords | Biotechnologie, Onkologie, Tumor Vaccine |
| Founded | 2006 |
| Employees | 1-10 |
| Socials |
Key Contact at Vaccentis
Martin Munte
Ceo
Vaccentis Email Formats
Vaccentis uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@vaccentis.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@vaccentis.com | 100% |
About Vaccentis
LATE STAGE DEVELOPMENT OF AN PROTEIN-BASED TUMOUR VACCINE FOR RENAL CELL CARCINOMA VCC MEDICAL DIVISION IS DEVELOPING CLINICALLY PROVEN PRODUCTS, SHOWN TO MAINTAIN REMISSION AND ALLEVIATE DISEASE VCC-001 cancer vaccine Phase III data in Renal Cell Cancer has demonstrated clinical effect and was well tolerated, a disease with few current treatment options VCC-001 cancer vaccine platform has significant potential in metastatic renal cell, colon and pancreatic cancers
Vaccentis revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Vaccentis has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
Vaccentis has never raised funding before.
Vaccentis Tech Stack
Discover the technologies and tools that power Vaccentis's digital infrastructure, from frameworks to analytics platforms.
Web servers
CMS
UI frameworks
JavaScript libraries
JavaScript libraries
Programming languages
Miscellaneous
Frequently asked questions
4.8
40,000 users



